Indication:

Dabigatran is indicated for Prevention of venous thromboembolic events in adult patients who have undergone major orthopaedic surgery of the lower limb (elective total hip or knee replacement). Prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation and at least one additional risk factor for stroke. Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and for the prevention of recurrent DVT and PE in adults.

Generic Name: Dabigatran

Strength: 110mg

Dosage: Caps

Shelflife Months: 24

Pack Size: 60

Tablet Description: White to pale yellow pellets in HPMC capsule size "0EL" Lt blue opq body & Lt cream opq cap imprinted "150" on body & "DAB" on cap in black ink

Segment :A

Innovator: Pradaxa ®

PBSListed: Yes

RPBSlisted: No

Schedule: S4

Storage Conditions: Store below 25 degrees Celsius

Active Ingredients: dabigatran etexilate mesilate 172.95mg
Equivalent: dabigatran etexilate 150mg

Warnings: